{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:55:00Z","timestamp":1793300100055,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146754"],"award-info":[{"award-number":["R01HL146754"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001491","name":"Belgian American Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frans Van de Werf Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11897-022-00569-8","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:04:57Z","timestamp":1659341097000},"page":"346-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Biomarkers for Myocarditis and Inflammatory Cardiomyopathy"],"prefix":"10.1007","volume":"19","author":[{"given":"Abhilash","family":"Suresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"569_CR1","first-page":"e007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy. Circulation: Heart Failure. 2020;13:e007405 (American Heart Association).","journal-title":"Circulation: Heart Failure"},{"key":"569_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","volume":"18","author":"C Tsch\u00f6pe","year":"2021","unstructured":"\u2022 Tsch\u00f6pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18:169\u201393. Excellent summary of the latest advances in cardio-immunology for myocarditis.","journal-title":"Nat Rev Cardiol"},{"key":"569_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcvm.2019.00048","volume":"6","author":"B Maisch","year":"2019","unstructured":"Maisch B. Cardio-immunology of myocarditis: focus on immune mechanisms and treatment options. Front Cardiovasc Med. 2019;6:48.","journal-title":"Front Cardiovasc Med"},{"key":"569_CR4","doi-asserted-by":"crossref","unstructured":"Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. 2016;118:496\u2013514 (American Heart Association).","DOI":"10.1161\/CIRCRESAHA.115.306573"},{"key":"569_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/s41598-022-05951-z","volume":"12","author":"M Fu","year":"2022","unstructured":"Fu M, Kontogeorgos S, Thunstr\u00f6m E, Zverkova Sandstr\u00f6m T, Kroon C, Bollano E, et al. Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014. Sci Rep. 2022;12:1810 (Nature Publishing Group).","journal-title":"Sci Rep"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","volume":"1003","author":"W Bracamonte-Baran","year":"2017","unstructured":"Bracamonte-Baran W, \u010cih\u00e1kov\u00e1 D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol. 2017;1003:187\u2013221.","journal-title":"Adv Exp Med Biol"},{"key":"569_CR7","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/j.jaci.2009.09.041","volume":"125","author":"C Castro","year":"2010","unstructured":"Castro C, Gourley M. Diagnostic testing and interpretation of tests for autoimmunity. J Allergy Clin Immunol. 2010;125:S238\u201347.","journal-title":"J Allergy Clin Immunol"},{"key":"569_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jacc.2020.11.074","volume":"77","author":"V Bang","year":"2021","unstructured":"Bang V, Ganatra S, Shah SP, Dani SS, Neilan TG, Thavendiranathan P, et al. Management of patients with giant cell myocarditis. J Am Coll Cardiol. 2021;77:1122\u201334 (American College of Cardiology Foundation).","journal-title":"J Am Coll Cardiol"},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"770549","DOI":"10.3389\/fcvm.2021.770549","volume":"8","author":"Y Hu","year":"2021","unstructured":"Hu Y, Ren J, Dong X, Zhang D, Qu Y, Yang C, et al. Fulminant giant cell myocarditis vs. lymphocytic myocarditis: a comparison of their clinical characteristics, treatments, and outcomes. Front Cardiovasc Med. 2021;8:770549.","journal-title":"Front Cardiovasc Med"},{"key":"569_CR10","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000001001","volume":"144","author":"YM Law","year":"2021","unstructured":"Law YM, Lal AK, Chen S, \u010cih\u00e1kov\u00e1 D, Cooper LT, Deshpande S, et al. Diagnosis and management of myocarditis in children. Circulation. 2021;144:e123\u201335 (American Heart Association).","journal-title":"Circulation"},{"key":"569_CR11","doi-asserted-by":"publisher","first-page":"e013365","DOI":"10.1161\/JAHA.119.013365","volume":"8","author":"KA Hoffman","year":"2019","unstructured":"Hoffman KA, Reynolds C, Bottazzi ME, Hotez P, Jones K. Improved biomarker and imaging analysis for characterizing progressive cardiac fibrosis in a mouse model of chronic chagasic cardiomyopathy. J Am Heart Assoc. 2019;8:e013365 (American Heart Association).","journal-title":"J Am Heart Assoc"},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","volume":"384","author":"R Blanco-Dom\u00ednguez","year":"2021","unstructured":"\u2022 Blanco-Dom\u00ednguez R, S\u00e1nchez-D\u00edaz R, de la Fuente H, Jim\u00e9nez-Borreguero LJ, Matesanz-Mar\u00edn A, Rela\u00f1o M, et al. A novel circulating MicroRNA for the detection of acute myocarditis. N Engl J Med. 2021;384:2014\u201327. New study identified a circulating microRNA related to the Th17 pathway that is specific for acute myocarditis in animal and human studies.    (Massachusetts Medical Society).","journal-title":"N Engl J Med"},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"e85851","DOI":"10.1172\/jci.insight.85851","volume":"1","author":"JM Myers","year":"2016","unstructured":"Myers JM, Cooper LT, Kem DC, Stavrakis S, Kosanke SD, Shevach EM, et al. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 2016;1:e85851.","journal-title":"JCI Insight"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.omtm.2020.05.005","volume":"17","author":"X Nie","year":"2020","unstructured":"Nie X, He M, Wang J, Chen P, Wang F, Lai J, et al. Circulating miR-4763-3p is a novel potential biomarker candidate for human adult fulminant myocarditis. Mol Ther - Methods Clin Dev. 2020;17:1079\u201387.","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"569_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12265-018-9814-0","volume":"11","author":"L Goldberg","year":"2018","unstructured":"Goldberg L, Tirosh-Wagner T, Vardi A, Abbas H, Pillar N, Shomron N, et al. Circulating MicroRNAs: a potential biomarker for cardiac damage, inflammatory response, and left ventricular function recovery in pediatric viral myocarditis. J Cardiovasc Transl Res. 2018;11:319\u201328.","journal-title":"J Cardiovasc Transl Res"},{"key":"569_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/CIRCGENETICS.114.000505","volume":"7","author":"S Omura","year":"2014","unstructured":"Omura S, Kawai E, Sato F, Martinez NE, Chaitanya GV, Rollyson PA, et al. Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis. Circ Cardiovasc Genet. 2014;7:444\u201354.","journal-title":"Circ Cardiovasc Genet"},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2020.04.048","volume":"75","author":"J Artico","year":"2020","unstructured":"Artico J, Merlo M, Delcaro G, Cannat\u00e0 A, Gentile P, De Angelis G, et al. Lymphocytic myocarditis: a genetically predisposed disease? J Am Coll Cardiol. 2020;75:3098\u2013100.","journal-title":"J Am Coll Cardiol"},{"key":"569_CR18","doi-asserted-by":"publisher","first-page":"e015289","DOI":"10.1161\/JAHA.119.015289","volume":"9","author":"W Poller","year":"2020","unstructured":"Poller W, Haas J, Klingel K, K\u00fchnisch J, Gast M, Kaya Z, et al. Familial recurrent myocarditis triggered by exercise in patients with a truncating variant of the desmoplakin gene. J Am Heart Assoc. 2020;9:e015289 (American Heart Association).","journal-title":"J Am Heart Assoc"},{"key":"569_CR19","doi-asserted-by":"publisher","first-page":"e002373","DOI":"10.1161\/CIRCGEN.118.002373","volume":"11","author":"K Reichl","year":"2018","unstructured":"Reichl K, Kreykes SE, Martin CM, Shenoy C. Desmoplakin variant-associated arrhythmogenic cardiomyopathy presenting as acute myocarditis. Circ Genom Precis Med. 2018;11:e002373.","journal-title":"Circ Genom Precis Med"},{"key":"569_CR20","first-page":"584","volume":"6","author":"AR Kontorovich","year":"2021","unstructured":"\u2022 Kontorovich AR, Patel N, Moscati A, Richter F, Peter I, Purevjav E, et al. Myopathic cardiac genotypes increase risk for myocarditis. JACC: Basic Transl Sci. 2021;6:584\u201392. New insights in genetic predisposition in patients presenting with concomitant acute myocarditis. (American College of Cardiology Foundation).","journal-title":"JACC: Basic Transl Sci"},{"key":"569_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/CIRCULATIONAHA.119.043545","volume":"142","author":"X Hua","year":"2020","unstructured":"Hua X, Hu G, Hu Q, Chang Y, Hu Y, Gao L, et al. Single-Cell RNA sequencing to dissect the immunological network of autoimmune myocarditis. Circulation. 2020;142:384\u2013400 (American Heart Association).","journal-title":"Circulation"},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/jir.2011.0057","volume":"31","author":"NR Rose","year":"2011","unstructured":"Rose NR. Critical cytokine pathways to cardiac inflammation. J Interferon Cytokine Res. 2011;31:705\u201310.","journal-title":"J Interferon Cytokine Res"},{"key":"569_CR23","doi-asserted-by":"publisher","first-page":"9575373","DOI":"10.1155\/2020\/9575373","volume":"2020","author":"Y Cai","year":"2020","unstructured":"Cai Y, Zhang X, Shen J, Jiang B, Hu D, Zhao M. Heparin-binding protein: a novel biomarker linking four different cardiovascular diseases. Cardiol Res Pract. 2020;2020:9575373.","journal-title":"Cardiol Res Pract"},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"e004125","DOI":"10.1161\/CIRCHEARTFAILURE.117.004125","volume":"10","author":"I M\u00fcller","year":"2017","unstructured":"M\u00fcller I, Vogl T, Pappritz K, Miteva K, Savvatis K, Rohde D, et al. Pathogenic role of the damage-associated molecular patterns S100A8 and S100A9 in Coxsackievirus B3-induced myocarditis. Circ Heart Fail. 2017;10:e004125.","journal-title":"Circ Heart Fail"},{"key":"569_CR25","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ehf2.12760","volume":"7","author":"I M\u00fcller","year":"2020","unstructured":"M\u00fcller I, Vogl T, K\u00fchl U, Krannich A, Banks A, Trippel T, et al. Serum alarmin S100A8\/S100A9 levels and its potential role as biomarker in myocarditis. ESC Heart Fail. 2020;7:1442\u201351.","journal-title":"ESC Heart Fail"},{"key":"569_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.20180722","volume":"216","author":"A Anzai","year":"2019","unstructured":"Anzai A, Mindur JE, Halle L, Sano S, Choi JL, He S, et al. Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis. J Exp Med. 2019;216:369\u201383.","journal-title":"J Exp Med"},{"key":"569_CR27","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/eji.201142209","volume":"42","author":"V Nindl","year":"2012","unstructured":"Nindl V, Maier R, Ratering D, De Giuli R, Z\u00fcst R, Thiel V, et al. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur J Immunol. 2012;42:2311\u201321.","journal-title":"Eur J Immunol"},{"key":"569_CR28","unstructured":"Interleukin-17A Is Dispensable for myocarditis but essential for the progression to dilated cardiomyopathy | Circulation Research [Internet]. [cited 2022 Mar 1]. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/circresaha.109.213157"},{"key":"569_CR29","doi-asserted-by":"publisher","first-page":"4396351","DOI":"10.1155\/2018\/4396351","volume":"2018","author":"D Vdovenko","year":"2018","unstructured":"Vdovenko D, Eriksson U. Regulatory role of CD4+ T cells in myocarditis. J Immunol Res. 2018;2018:4396351.","journal-title":"J Immunol Res"},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fimmu.2020.00539","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Han B. Dysregulated CD4+ T cells and microRNAs in myocarditis. Front Immunol. 2020;11:539.","journal-title":"Front Immunol"},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jmv.25378","volume":"91","author":"X Wang","year":"2019","unstructured":"Wang X, Ge J, Chen R. LAP+ Treg is a better biomarker than total Treg in viral myocarditis. J Med Virol. 2019;91:886\u20139.","journal-title":"J Med Virol"},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cvr\/cvy034","volume":"114","author":"J Song","year":"2018","unstructured":"Song J, Chen X, Cheng L, Rao M, Chen K, Zhang N, et al. Vitamin D receptor restricts T helper 2-biased inflammation in the heart. Cardiovasc Res. 2018;114:870\u20139.","journal-title":"Cardiovasc Res"},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aav3487","volume":"366","author":"C Gil-Cruz","year":"2019","unstructured":"Gil-Cruz C, Perez-Shibayama C, De Martin A, Ronchi F, van der Borght K, Niederer R, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. 2019;366:881\u20136.","journal-title":"Science"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1161\/CIRCULATIONAHA.118.033890","volume":"138","author":"X Chen","year":"2018","unstructured":"Chen X, Zeng X-H, Wang M, Chen L, Zhang N, Rao M, et al. Bcl2-like protein 12 is required for the aberrant T helper-2 polarization in the heart by enhancing interleukin-4 expression and compromising apoptotic machinery in CD4+ T cells. Circulation. 2018;138:2559\u201368 (American Heart Association).","journal-title":"Circulation"},{"key":"569_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","volume":"110","author":"Z Kaya","year":"2012","unstructured":"Kaya Z, Leib C, Katus HA. Autoantibodies in heart failure and cardiac dysfunction. Circ Res. 2012;110:145\u201358.","journal-title":"Circ Res"},{"key":"569_CR36","doi-asserted-by":"publisher","first-page":"108455","DOI":"10.1016\/j.clim.2020.108455","volume":"217","author":"A Matsumori","year":"2020","unstructured":"Matsumori A, Shimada T, Nakatani E, Shimada M, Tracy S, Chapman NM, et al. Immunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis. Clin Immunol. 2020;217:108455.","journal-title":"Clin Immunol"},{"key":"569_CR37","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JPM, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110:3121\u20138 (American Heart Association).","journal-title":"Circulation"},{"key":"569_CR38","doi-asserted-by":"publisher","first-page":"e003804","DOI":"10.1161\/CIRCHEARTFAILURE.116.003804","volume":"10","author":"C Besler","year":"2017","unstructured":"Besler C, Lang D, Urban D, Rommel K-P, von Roeder M, Fengler K, et al. Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: implications for its use as a biomarker. Circ Heart Fail. 2017;10:e003804.","journal-title":"Circ Heart Fail"},{"key":"569_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676\u201389 (Nature Publishing Group).","journal-title":"Nat Rev Immunol"},{"key":"569_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT. The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7:827\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"569_CR41","doi-asserted-by":"publisher","first-page":"e008968","DOI":"10.1161\/JAHA.118.008968","volume":"8","author":"MJ Coronado","year":"2019","unstructured":"Coronado MJ, Bruno KA, Blauwet LA, Tsch\u00f6pe C, Cunningham MW, Pankuweit S, et al. Elevated sera sST2 is associated with heart failure in men \u226450 years old with myocarditis. J Am Heart Assoc. 2019;8:e008968.","journal-title":"J Am Heart Assoc"},{"key":"569_CR42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1503\/cmaj\/051291","volume":"173","author":"L Babuin","year":"2005","unstructured":"Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005;173:1191\u2013202.","journal-title":"CMAJ"},{"key":"569_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0009-8981(95)06168-1","volume":"245","author":"J Mair","year":"1996","unstructured":"Mair J, Genser N, Morandell D, Maier J, Mair P, Lechleitner P, et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta. 1996;245:19\u201338.","journal-title":"Clin Chim Acta"},{"key":"569_CR44","doi-asserted-by":"publisher","first-page":"e013757","DOI":"10.1161\/JAHA.119.013757","volume":"9","author":"N Palaskas","year":"2020","unstructured":"Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc. 2020;9:e013757.","journal-title":"J Am Heart Assoc"},{"key":"569_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaccao.2021.01.004","volume":"3","author":"S Waliany","year":"2021","unstructured":"Waliany S, Neal JW, Reddy S, Wakelee H, Shah SA, Srinivas S, et al. Myocarditis surveillance with high-sensitivity troponin I during cancer treatment with immune checkpoint inhibitors. JACC CardioOncol. 2021;3:137\u20139.","journal-title":"JACC CardioOncol"},{"key":"569_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12872-021-02386-8","volume":"21","author":"C Liu","year":"2021","unstructured":"Liu C, Wang Z, Chen K, Cui G, Chen C, Wang L, et al. The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis. BMC Cardiovasc Disord. 2021;21:571.","journal-title":"BMC Cardiovasc Disord"},{"key":"569_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/hrt.2005.071233","volume":"92","author":"M Weber","year":"2006","unstructured":"Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92:843\u20139.","journal-title":"Heart"},{"key":"569_CR48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/heart.89.2.150","volume":"89","author":"M Bay","year":"2003","unstructured":"Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003;89:150\u20134.","journal-title":"Heart"},{"key":"569_CR49","doi-asserted-by":"publisher","first-page":"zuab020.189","DOI":"10.1093\/ehjacc\/zuab020.189","volume":"10","author":"B Sara","year":"2021","unstructured":"Sara B, Monteiro J, Carvalho P, Ribeiro Carvalho C, Chemba J, Ferreira C, et al. Are high NT-proBNP levels more related to inflammation than to left ventricular systolic dysfunction in acute myocarditis? Eur Heart J Acute Cardiovasc Care. 2021;10:zuab020.189.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"569_CR50","doi-asserted-by":"publisher","first-page":"e0158299","DOI":"10.1371\/journal.pone.0158299","volume":"11","author":"U Grabmaier","year":"2016","unstructured":"Grabmaier U, Kania G, Kreiner J, Grabmeier J, Uhl A, Huber BC, et al. Soluble vascular cell adhesion molecule-1 (VCAM-1) as a biomarker in the mouse model of experimental autoimmune myocarditis (EAM). PLoS ONE. 2016;11:e0158299 (Public Library of Science).","journal-title":"PLoS ONE"},{"key":"569_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1017\/S1047951114002327","volume":"25","author":"M Argun","year":"2015","unstructured":"Argun M, Baykan A, Narin F, \u00d6zyurt A, Pamuk\u00e7u \u00d6, Elmal\u0131 F, et al. Plasma gelsolin as a biomarker of acute rheumatic carditis. Cardiol Young. 2015;25:1276\u201380.","journal-title":"Cardiol Young"},{"key":"569_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1017\/S1047951113001820","volume":"25","author":"BD Kaufman","year":"2015","unstructured":"Kaufman BD, Videon N, Zhang X, Harris MA, Shaddy RE, Goldmuntz E. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy. Cardiol Young. 2015;25:228\u201336.","journal-title":"Cardiol Young"},{"key":"569_CR53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/tropej\/fmt058","volume":"59","author":"Z Karatas","year":"2013","unstructured":"Karatas Z, Baysal T, Alp H, Toker A. Serum tenascin-C: a novel biomarker for diagnosis and predicting prognosis of rheumatic carditis? J Trop Pediatr. 2013;59:476\u201382.","journal-title":"J Trop Pediatr"},{"key":"569_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1253\/circj.CJ-14-1192","volume":"79","author":"A Frustaci","year":"2015","unstructured":"Frustaci A, Chimenti C. Immunosuppressive therapy in myocarditis. Circ J. 2015;79:4\u20137.","journal-title":"Circ J"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-022-00569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-022-00569-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-022-00569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:55:12Z","timestamp":1744156512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-022-00569-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s11897-022-00569-8","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"20 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Suresh has no relationships to disclose. Dr. Martens is supported by a grant from the Belgian American Educational Foundation (BAEF) and by the Frans Van de Werf Fund. Dr. Tang is a consultant for Sequana Medical A.V., Cardiol Therapeutics Inc, Genomics plc, Zehna Therapeutics Inc, Renovacor Inc, and has received honorarium from Springer Nature for authorship\/editorship and American Board of Internal Medicine for exam writing committee participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}